Portage Biotech earnings were -$6.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest PRTG earnings report on Mar 31, 2025 announced Q1 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, PRTG reported annual earnings of -$6.8M, with -91% growth. The next PRTG earnings date is Aug 25, 2025.
What were Portage Biotech's earnings last quarter?
Portage Biotech (NASDAQ: PRTG) reported Q1 2025 earnings per share (EPS) of N/A, up N/A year over year. Total PRTG earnings for the quarter were N/A. In the same quarter last year, Portage Biotech's earnings per share (EPS) was -$24.23.
The next PRTG earnings call is Invalid Date. Add PRTG to your watchlist to be reminded of Portage Biotech's next earnings date.
What was PRTG's earnings growth in the past year?
As of Portage Biotech's earnings date in Q3 2025, Portage Biotech's earnings has grown year over year. PRTG earnings in the past year totalled -$6.78 million.
Is Portage Biotech profitable or losing money?
As of the last Portage Biotech earnings report, Portage Biotech is currently losing money. Portage Biotech's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$6.78 million, a 91.01% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.